Systemic Hypoxia Increases the Expression of DPP4 in Preadipocytes of Healthy Human Participants

Helena H Chowdhury1,2, Jelena Velebit1,2, Igor B Mekjavic3

  • 1Laboratory for Neuroendocrinology - Molecular Cell Physiology, Institute of Pathophysiology, Faculty of Medicine, University of Ljubljana, Zaloška 4, Ljubljana, Slovenia.

Insights

Hypoxia significantly increases dipeptidyl peptidase 4 (DPP4) expression in human fat cells, suggesting DPP4 may indicate tissue hypoxia in obesity. Inactivity alone had no effect.

Area of Science:

  • Biochemistry
  • Endocrinology
  • Metabolic Research

Background:

  • Dipeptidyl peptidase 4 (DPP4) is a protein linked to incretin metabolism.
  • DPP4 plays a role in insulin secretion and is a therapeutic target for type 2 diabetes.
  • Understanding DPP4 regulation in adipose tissue is crucial for metabolic health.

Purpose of the Study:

  • To investigate the effects of hypoxia and physical inactivity on DPP4 expression in human adipose tissue.
  • To determine if DPP4 can serve as a biomarker for tissue hypoxia.

Main Methods:

  • Human adipose tissue biopsies were collected from 12 normal-weight males.
  • Preadipocytes were isolated and exposed to experimental conditions simulating hypoxia and inactivity.
  • DPP4 expression levels were measured under different experimental conditions.

Main Results:

  • Hypoxia significantly increased DPP4 expression in isolated human preadipocytes.
  • Physical inactivity alone did not significantly affect DPP4 expression.
  • Combined effects were not explicitly detailed but hypoxia was the primary driver.

Conclusions:

  • DPP4 expression in adipose tissue is sensitive to hypoxic conditions.
  • DPP4 may serve as an indirect marker for monitoring tissue hypoxia.
  • Findings are relevant to understanding metabolic alterations in conditions like obesity.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.7K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.7K
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
759